The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Karyopharm Therapeutics
A phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naïve myelofibrosis.
 
Haris Ali
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Incyte
 
Ashwin Kishtagari
No Relationships to Disclose
 
Keri Renee Maher
Consulting or Advisory Role - SOBI
 
Sanjay Mohan
Research Funding - Incyte (Inst); Karyopharm Therapeutics (Inst); Taiho Oncology (Inst)
 
Amitabha Mazumder
No Relationships to Disclose
 
Kamal Chamoun
No Relationships to Disclose
 
Igor Karasik
Employment - Karyopharm Therapeutics
 
Eric Sbar
Employment - Karyopharm Therapeutics
 
Laura Dugon
Employment - Karyopharm Therapeutics
 
Sharon Tamir
Employment - Karyopharm Therapeutics
 
Xulong Wang
Employment - Karyopharm Therapeutics
 
Josef T. Prchal
No Relationships to Disclose
 
Srinivas Kiran Tantravahi
Honoraria - Karyopharm Therapeutics; Novartis
Consulting or Advisory Role - Karyopharm Therapeutics; Novartis
Research Funding - Karyopharm Therapeutics